MedTrace Logo

Intranasal Delivery of Testosterone and Its Effect on Doping Markers

NCT02611154 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2020-02-11

Study results available
· View outcomes & findings →

Summary

Hypothesis: Intranasal administration of exogenous testosterone results in a characteristic profile during anti-doping testing, which is different than the profile seen when testosterone is administered into muscle, on skin or under the tongue.

Objective: The investigators aim to characterize the unique steroid doping profile following administration of intranasal testosterone to healthy, active volunteer subjects.

Conditions

  • Abuse of Anabolic Steroids

Interventions

DRUG

Testosterone

Participants will self-administer 11 mg 3x daily, for 5 consecutive days for 4 weeks.

Sponsors & Collaborators

  • Sports Medicine Research and Testing Laboratory

    collaborator INDUSTRY

  • Partnership for Clean Competition

    collaborator OTHER

  • University of Utah

    lead OTHER

Principal Investigators

  • Stuart Willick, MD · University of Utah

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-11-18
Primary Completion
2016-01-19
Completion
2016-01-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02611154 on ClinicalTrials.gov